Interleukin-12 encoded by the oncolytic virus VSV-GP enhances therapeutic antitumor efficacy by inducing CD8+ T-cell responses with a long-lived effector cell phenotypeZoltán Bánki, Tobias Nolden, Liesa-Marie Schreiber et al.|Journal for ImmunoTherapy of Cancer|2025Cited by 9
Oncolytic virus-delivered GSDME: Unlocking pyroptosis to improve dendritic cell function and amplify cytotoxic T cell responseSabrina Schneider, Tobias Nolden, Theresa Schwaiger et al.|Molecular Therapy Oncology|2026Cited by 0